Quality Control Laboratories

A pharmaceutical quality control laboratory evaluates samples through analytical testing. WHO’s revised laboratory guidance distinguishes routine compliance samples, including those associated with marketing authorization, from investigative samples involving suspected illegal, falsified, or substandard products. These categories explain why laboratories may receive samples for different purposes. They do not establish how frequently each kind of investigation occurs in Iran. s1

Laboratory work belongs within a wider system of quality assurance. WHO’s pharmaceutical guidance covers development, manufacturing, quality control, and surveillance after products reach the market. This broader perspective is useful for understanding Iran’s pharmaceutical sector: a discussion confined to testing would leave out other stages addressed by international quality guidance. The compendium provides a framework, rather than an assessment of Iranian regulatory outcomes. s2

[s1] [s2]

WHO guidance calls for an effective chain of custody: a record of the sample’s identity and handling. Sampling records should capture relevant details such as the method, timing, personnel, and transport conditions. Incoming sample information includes the product description, batch details where available, the reason for analysis, applicable specifications, and storage requirements. The laboratory should check whether it has enough material and the capability to perform the requested tests. s1

The guidance also addresses analytical methods, technical records, evaluation of results, measurement uncertainty, and results outside specifications. These topics show that dependable testing involves a documented process around the measurement, rather than an instrument reading alone. They are international expectations; this page does not claim that particular Iranian laboratories have demonstrated compliance. s1

[s1]

The current evidence is insufficient for a reliable directory or evaluation of Iranian quality control laboratories. It does not establish which facilities perform which tests, the scope and validity of their accreditation, or their recent inspection outcomes. Accordingly, this page names no laboratory as currently approved or internationally recognized.

WHO’s compendium is useful for organizing that further research because it connects laboratory testing with manufacturing and post-marketing oversight. It cannot substitute for facility-specific records or national surveillance evidence. Claims about the quality of Iran’s medicine supply would need evidence about actual products and regulatory findings, rather than the existence of guidance alone. s2

The practical conclusion is an evidence boundary: international documents explain what quality assurance seeks to accomplish, while a substantive assessment of Iran’s laboratory system still requires verified institutional and performance records. This page remains a research draft until those records can support a country-specific account.

[s2]